This is a table of type bigram and their frequencies. Use it to search & browse the list to learn more about your study carrel.
bigram | frequency |
---|---|
guinea pigs | 507 |
guinea pig | 230 |
clinical signs | 210 |
respiratory syndrome | 209 |
porcine reproductive | 196 |
syndrome virus | 162 |
infected pigs | 112 |
immune responses | 95 |
porcine circovirus | 87 |
immune response | 77 |
respiratory disease | 74 |
influenza virus | 72 |
pigs infected | 67 |
dko pigs | 61 |
outbreak herds | 61 |
swine influenza | 61 |
pig farmers | 60 |
control pigs | 58 |
body weight | 57 |
circovirus type | 55 |
pig traders | 53 |
exposed controls | 52 |
virus infection | 51 |
lymph nodes | 50 |
porcine epidemic | 48 |
clinical disease | 48 |
respiratory tract | 48 |
prrsv infection | 48 |
heat stress | 47 |
amino acid | 46 |
united states | 46 |
transgenic pigs | 44 |
present study | 43 |
air samples | 42 |
epidemic diarrhea | 42 |
infected animals | 41 |
diarrhea virus | 39 |
innate immune | 39 |
porcine respiratory | 38 |
swine fever | 37 |
immune system | 37 |
inoculated pigs | 37 |
time pcr | 36 |
transmissible gastroenteritis | 36 |
pig buildings | 35 |
small intestine | 34 |
genome editing | 34 |
crispr cas | 33 |
animal models | 33 |
wt pigs | 32 |
doc id | 32 |
cord uid | 32 |
lung lesions | 32 |
parainfluenza virus | 31 |
nk cells | 31 |
iv strains | 31 |
serum samples | 30 |
sf sf | 30 |
domestic pigs | 30 |
clinical manifestations | 30 |
wild pigs | 30 |
neutralizing antibodies | 29 |
pigs inoculated | 29 |
nipah virus | 29 |
mg kg | 29 |
significantly higher | 29 |
highly pathogenic | 28 |
pig model | 28 |
viral infections | 28 |
actinobacillus pleuropneumoniae | 28 |
pig production | 27 |
pig id | 27 |
previously described | 27 |
pigs exposed | 27 |
porcine endogenous | 26 |
mycoplasma hyopneumoniae | 26 |
nasopharynx samples | 26 |
nasopharyngeal flora | 25 |
animal species | 25 |
prrsv strain | 25 |
genetically modified | 25 |
negative controls | 25 |
interstitial pneumonia | 25 |
chadox ncov | 25 |
live pigs | 25 |
epithelial cells | 25 |
gene segments | 25 |
may also | 25 |
gastroenteritis virus | 24 |
significant differences | 24 |
animal model | 24 |
tf tf | 24 |
animal health | 24 |
challenged pigs | 24 |
economic losses | 24 |
pigs per | 24 |
like particles | 24 |
swine iv | 24 |
antibody responses | 23 |
viral rna | 23 |
dendritic cells | 23 |
sales data | 23 |
african swine | 23 |
peripheral blood | 23 |
bordetella bronchiseptica | 23 |
previous study | 22 |
days post | 22 |
bone marrow | 22 |
laboratory animals | 22 |
antibody response | 22 |
antigenic sites | 22 |
adaptive immune | 22 |
statistically significant | 22 |
van hoosier | 21 |
cell lines | 21 |
influenza viruses | 21 |
sendai virus | 21 |
knockout pigs | 21 |
contact pigs | 20 |
significant difference | 20 |
additional file | 20 |
affected animals | 20 |
weight gain | 20 |
escherichia coli | 20 |
adrenal gland | 20 |
direct contact | 20 |
lymph node | 20 |
mean group | 20 |
mononuclear cells | 20 |
experimental infection | 20 |
pigs compared | 20 |
control group | 20 |
proinflammatory cytokines | 19 |
pdcov infection | 19 |
cell responses | 19 |
north american | 19 |
respiratory coronavirus | 19 |
fisher scientific | 19 |
streptobacillus moniliformis | 19 |
applied biosystems | 19 |
one pig | 19 |
pig herds | 19 |
acute respiratory | 19 |
nonhuman primates | 19 |
pig farms | 19 |
porcine parvovirus | 18 |
laboratory guinea | 18 |
reproductive failure | 18 |
wasting syndrome | 18 |
high mortality | 18 |
blood samples | 18 |
previous studies | 18 |
vaccine development | 18 |
growing pigs | 18 |
performance herds | 18 |
public health | 18 |
may result | 18 |
pigs may | 18 |
nuclear transfer | 18 |
pigs sampled | 18 |
infectious diseases | 18 |
alveolar macrophages | 18 |
lung tissues | 17 |
upper respiratory | 17 |
sequences obtained | 17 |
cytokine levels | 17 |
adaptive immunity | 17 |
balf samples | 17 |
current study | 17 |
thermo fisher | 17 |
gene editing | 17 |
nasal discharge | 17 |
tl co | 17 |
pig farmer | 17 |
lung tissue | 17 |
modified pigs | 17 |
gene expression | 16 |
two groups | 16 |
important role | 16 |
virus replication | 16 |
prrsv isolates | 16 |
fecal samples | 16 |
endothelial cells | 16 |
amino acids | 16 |
innate immunity | 16 |
rectal temperatures | 16 |
total number | 16 |
high morbidity | 16 |
two pigs | 16 |
nucleotide level | 15 |
virus infections | 15 |
production systems | 15 |
pigs coinfected | 15 |
wastewater workers | 15 |
traders operating | 15 |
two different | 15 |
human cd | 15 |
pedv rna | 15 |
clostridium difficile | 15 |
tcid ml | 15 |
chlamydia spp | 15 |
classical swine | 15 |
based vaccine | 15 |
stimulating factor | 15 |
endogenous retroviruses | 15 |
body temperature | 15 |
sham inoculated | 15 |
pig population | 15 |
viral replication | 15 |
acid level | 15 |
prrsv challenged | 14 |
also known | 14 |
polymerase chain | 14 |
co hb | 14 |
source data | 14 |
flow cytometry | 14 |
relative abundance | 14 |
acute phase | 14 |
pig cells | 14 |
chain reaction | 14 |
per animal | 14 |
sample size | 14 |
farm gate | 14 |
resistance genes | 14 |
pathogenic porcine | 14 |
performed using | 14 |
nervous system | 14 |
antibody titres | 14 |
treatment groups | 14 |
feral swine | 14 |
pcv antigen | 14 |
internal gene | 14 |
per pig | 14 |
negative control | 14 |
disease complex | 13 |
risk factors | 13 |
statistical analysis | 13 |
secondary bacterial | 13 |
xenograft rejection | 13 |
pig colonies | 13 |
wasting disease | 13 |
large animal | 13 |
equi subsp | 13 |
virus isolation | 13 |
inflammatory cytokines | 13 |
immunosorbent assay | 13 |
smallholder pig | 13 |
plga nps | 13 |
per group | 13 |
bioaerosol exposure | 13 |
bronchoalveolar lavage | 13 |
stomach wall | 13 |
intestinal contents | 13 |
differential abundance | 13 |
vaccine delivery | 13 |
antimicrobial resistance | 13 |
zoonotic potential | 13 |
rectal temperature | 13 |
one study | 13 |
ex vivo | 13 |
viral load | 13 |
animal care | 12 |
monoclonal antibody | 12 |
endogenous retrovirus | 12 |
disease resistance | 12 |
pulmonary function | 12 |
porcine viral | 12 |
survival time | 12 |
signs include | 12 |
laboratory animal | 12 |
infected guinea | 12 |
sus scrofa | 12 |
pedv infection | 12 |
recombinant human | 12 |
cell population | 12 |
inflammatory response | 12 |
lung parenchyma | 12 |
transgenic pig | 12 |
described previously | 12 |
mg ml | 12 |
type i | 12 |
room temperature | 12 |
gross lesions | 12 |
antimicrobial consumption | 12 |
porcine pleuropneumonia | 12 |
mouth disease | 12 |
porcine genome | 12 |
blood cell | 12 |
like particle | 12 |
disease outbreaks | 12 |
young guinea | 12 |
human complement | 12 |
antimicrobial use | 12 |
human parainfluenza | 12 |
three groups | 12 |
data obtained | 12 |
naturally occurring | 12 |
weight loss | 12 |
cd cd | 12 |
ggta knock | 12 |
treated pigs | 12 |
pig trader | 12 |
tissue samples | 12 |
pig populations | 12 |
linked immunosorbent | 12 |
cell response | 12 |
three times | 12 |
pig industry | 12 |
weight ratio | 12 |
swine herds | 12 |
fever virus | 12 |
type porcine | 12 |
human blood | 12 |
otitis media | 12 |
blood mononuclear | 12 |
bal cells | 12 |
prrsv rna | 12 |
early stages | 11 |
trixacarus caviae | 11 |
small farms | 11 |
hemagglutinating encephalomyelitis | 11 |
virus vaccine | 11 |
postmortem examination | 11 |
weaned pigs | 11 |
heat shock | 11 |
exposed control | 11 |
central nervous | 11 |
histopathologic lesions | 11 |
alpha diversity | 11 |
calculated using | 11 |
infectious agents | 11 |
fc treatment | 11 |
cavia porcellus | 11 |
natural infection | 11 |
experimentally infected | 11 |
rna virus | 11 |
virus strain | 11 |
old pigs | 11 |
immune cells | 11 |
day post | 11 |
acds per | 11 |
incubation period | 11 |
virus challenge | 11 |
high fever | 11 |
prrsv antibody | 11 |
microscopic lung | 11 |
encephalitozoon cuniculi | 11 |
prrsv isolate | 11 |
pet guinea | 11 |
electron microscopy | 11 |
niv infection | 11 |
streptococcus suis | 11 |
natural infections | 11 |
infectious disease | 11 |
cytokines measured | 11 |
time points | 11 |
bacterial infections | 11 |
time point | 11 |
prrsv challenge | 11 |
sick pigs | 11 |
class i | 11 |
viral loads | 11 |
ri wkh | 11 |
causative agent | 11 |
causative organism | 11 |
cloned pigs | 11 |
significantly elevated | 11 |
farmer samples | 11 |
large white | 11 |
buffered formalin | 11 |
pcv dna | 11 |
pigs using | 10 |
based vaccines | 10 |
previous reports | 10 |
gnotobiotic pigs | 10 |
pedv pigs | 10 |
early weaning | 10 |
per kg | 10 |
prrsv alone | 10 |
protective immunity | 10 |
pigs also | 10 |
transgenic expression | 10 |
mortality rate | 10 |
group mean | 10 |
lower respiratory | 10 |
higher levels | 10 |
secondary infections | 10 |
affected pigs | 10 |
hev gt | 10 |
ha sequences | 10 |
poor performance | 10 |
swine industry | 10 |
became sick | 10 |
clinical symptoms | 10 |
commercially available | 10 |
srcr domain | 10 |
times greater | 10 |
oral cavity | 10 |
viral clearance | 10 |
naturally infected | 10 |
prrsv antigen | 10 |
airway resistance | 10 |
pigs exhibited | 10 |
tissue culture | 10 |
pedv group | 10 |
single dose | 10 |
recent study | 10 |
kg body | 10 |
positive pigs | 10 |
lawsonia intracellularis | 10 |
acute death | 10 |
nasal cavity | 10 |
finishing pigs | 10 |
pig adenovirus | 10 |
infection dynamics | 10 |
coinfected groups | 10 |
domestic pig | 10 |
cervical lymphadenitis | 10 |
trichophyton mentagrophytes | 10 |
papn knockout | 10 |
agriculture organization | 10 |
lymphoid tissues | 10 |
disease virus | 10 |
good performance | 10 |
neurological disease | 10 |
biomedical research | 10 |
samples collected | 10 |
phylogenetic analysis | 10 |
significantly lower | 10 |
wt group | 10 |
pigs showed | 10 |
survival rates | 10 |
respiratory rate | 10 |
tracheobronchial lymph | 10 |
dc macrophage | 10 |
clostridium piliforme | 10 |
per ml | 10 |
edited pigs | 10 |
somatic cell | 10 |
another study | 10 |
dairy cows | 10 |
white blood | 10 |
buffered saline | 10 |
pig herd | 10 |
elevated levels | 10 |
nursery pigs | 10 |
avian influenza | 10 |
finisher site | 10 |
yersinia pseudotuberculosis | 9 |
whole tree | 9 |
relative abundances | 9 |
price paid | 9 |
cell epitopes | 9 |
cd cells | 9 |
prrsv strains | 9 |
pigs experimentally | 9 |
exposed individuals | 9 |
average daily | 9 |
viral challenge | 9 |
nasopharyngeal samples | 9 |
strain vr | 9 |
vaccinated pigs | 9 |
porcine plasma | 9 |
human health | 9 |
miniature pigs | 9 |
authors declare | 9 |
key role | 9 |
control animals | 9 |
clostridium perfringens | 9 |
genetically engineered | 9 |
rjxwn challenge | 9 |
cytomegalovirus infection | 9 |
health status | 9 |
stem cells | 9 |
case pigs | 9 |
lymphocytic choriomeningitis | 9 |
streptococcus pneumoniae | 9 |
diversity measures | 9 |
two guinea | 9 |
porcine cell | 9 |
vaccinated animals | 9 |
neutralizing antibody | 9 |
sequence analysis | 9 |
pigs due | 9 |
chitosan nps | 9 |
human diseases | 9 |
considered positive | 9 |
growth performance | 9 |
haemophilus parasuis | 9 |
hendra virus | 9 |
pigs challenged | 9 |
pig cytomegalovirus | 9 |
cell culture | 9 |
standard curve | 9 |
bovsdp pigs | 9 |
wild pig | 9 |
specific antibody | 9 |
highly conserved | 9 |
differentially abundant | 9 |
factors associated | 9 |
pulmonary lesions | 9 |
impulse oscillometry | 9 |
conventional pigs | 9 |
severe acute | 9 |
randomly assigned | 9 |
positive samples | 9 |
cystic fibrosis | 9 |
ii cells | 9 |
cell line | 9 |
cytokine production | 9 |
diffi cult | 9 |
neutralising antibodies | 9 |
state university | 9 |
experimentally induced | 9 |
cell cultures | 9 |
herpes virus | 9 |
individual pigs | 9 |
humoral immune | 9 |
virus shedding | 9 |
lamina propria | 9 |
significant increase | 9 |
igg antibodies | 9 |
macrophage colony | 9 |
experimental infections | 9 |
porcine cytomegalovirus | 9 |
complete blood | 9 |
wastewater treatment | 9 |
multisystemic wasting | 9 |
domestic animals | 9 |
solid organ | 9 |
swine populations | 9 |
cell surface | 9 |
cfu ml | 9 |
clinical application | 9 |
staphylococcus aureus | 8 |
stock virus | 8 |
challenge group | 8 |
european countries | 8 |
respiratory distress | 8 |
reverse transcription | 8 |
supplementary material | 8 |
animal welfare | 8 |
two doses | 8 |
principal coordinate | 8 |
pigs became | 8 |
veterinary medicine | 8 |
regulatory proteins | 8 |
airway obstruction | 8 |
ovarian cysts | 8 |
germ cells | 8 |
final visit | 8 |
national level | 8 |
pig health | 8 |
supplementary file | 8 |
human serum | 8 |
identifi ed | 8 |
mucosal iga | 8 |
analyzed using | 8 |
pneumonia virus | 8 |
closely related | 8 |
inclusion conjunctivitis | 8 |
new zealand | 8 |
chlamydial infection | 8 |
mouse igg | 8 |
human pathogens | 8 |
encephalomyelitis virus | 8 |
genotype prrsv | 8 |
affected guinea | 8 |
clinical trials | 8 |
significantly different | 8 |
human cells | 8 |
case report | 8 |
economically important | 8 |
large amounts | 8 |
cell nuclear | 8 |
gal antigen | 8 |
embryonic death | 8 |
proinflammatory cytokine | 8 |
significantly increased | 8 |
gal antibodies | 8 |
north america | 8 |
genbank accession | 8 |
diagnostic tests | 8 |
pasteurella multocida | 8 |
pig sera | 8 |
specific antibodies | 8 |
prrs virus | 8 |
peripheral airway | 8 |
chlamydia suis | 8 |
high levels | 8 |
data collection | 8 |
domestic swine | 8 |
cell subsets | 8 |
large number | 8 |
vivo perfusion | 8 |
antimicrobial agents | 8 |
pig kidney | 8 |
specific pathogen | 8 |
healthy pigs | 8 |
exposure assessment | 8 |
natural killer | 8 |
microscopic lesions | 8 |
salmonella spp | 8 |
field conditions | 8 |
pigs remained | 8 |
cd knockout | 8 |
cellular immune | 8 |
lavage fluid | 8 |
results obtained | 8 |
adapted iv | 8 |
bacterial community | 8 |
treatment intensity | 8 |
hb kg | 8 |
days prior | 8 |
blood vessels | 8 |
muscular dystrophy | 8 |
lf lf | 8 |
inoculated controls | 8 |
pons medulla | 8 |
danish pig | 8 |
protective immune | 8 |
infected group | 8 |
significantly greater | 8 |
inoculated control | 8 |
gt knockout | 8 |
viral infection | 8 |
female guinea | 8 |
quantitative real | 8 |
nasal swabs | 8 |
pig organs | 8 |
weight body | 8 |
atcc vr | 8 |
fl ora | 8 |
heart rate | 8 |
conjunctival swabs | 8 |
xenograft survival | 8 |
human disease | 8 |
master mix | 8 |
respiratory signs | 8 |
dko group | 8 |
porcine cd | 8 |
clinical presentation | 8 |
south america | 8 |
iga antibody | 8 |
pseudorabies virus | 8 |
eight pigs | 8 |
recent years | 8 |
niv vaccine | 8 |
kag vaccine | 8 |
bacterial culture | 8 |
associated disease | 8 |
tissue sections | 8 |
also reported | 7 |
toxoplasma gondii | 7 |
commonly used | 7 |
antibody levels | 7 |
fattening pigs | 7 |
cytokine genes | 7 |
antibiotic treatment | 7 |
cynomolgus monkeys | 7 |
porcine deltacoronavirus | 7 |
pathological lesions | 7 |
necrosis factor | 7 |
different amino | 7 |
syndrome viruses | 7 |
pigs date | 7 |
online version | 7 |
organ xenotransplantation | 7 |
shock protein | 7 |
response compared | 7 |
mortality rates | 7 |
postweaning multisystemic | 7 |
acid sequence | 7 |
later stages | 7 |
mammary gland | 7 |
virus neutralizing | 7 |
blood agar | 7 |
may become | 7 |
macrophage network | 7 |
blood cells | 7 |
neutralising antibody | 7 |
infected swine | 7 |
pigs expressing | 7 |
different animal | 7 |
villous atrophy | 7 |
pigs developed | 7 |
vaccine candidate | 7 |
log transformed | 7 |
antigen uptake | 7 |
selective breeding | 7 |
nasal secretion | 7 |
identified deps | 7 |
liver failure | 7 |
microbial community | 7 |
per cent | 7 |
brain tissue | 7 |
carrier state | 7 |
pigs died | 7 |
also collected | 7 |
host immune | 7 |
norwegian pig | 7 |
acute liver | 7 |
van gorp | 7 |
supplementary table | 7 |
expressing human | 7 |
unifrac distance | 7 |
pd whole | 7 |
molecular epidemiology | 7 |
xenotransplantation using | 7 |
commercial vaccines | 7 |
cd cell | 7 |
pigs porcine | 7 |
large farms | 7 |
signs associated | 7 |
severe disease | 7 |
life technologies | 7 |
san diego | 7 |
porcine cells | 7 |
antimicrobial usage | 7 |
strain guinea | 7 |
finisher pigs | 7 |
donor cells | 7 |
intestinal epithelium | 7 |
respiratory mechanics | 7 |
stress response | 7 |
porcine alveolar | 7 |
pathological changes | 7 |
health management | 7 |
ex hz | 7 |
gene segment | 7 |
liver regeneration | 7 |
iav infection | 7 |
histopathologic examination | 7 |
white pigs | 7 |
different superscripts | 7 |
economic impact | 7 |
indicates significant | 7 |
occupational exposure | 7 |
reproductive performance | 7 |
cells using | 7 |
peptide pools | 7 |
foster city | 7 |
bd biosciences | 7 |
stranded rna | 7 |
five pigs | 7 |
diagnosis diagnosis | 7 |
outbreak herd | 7 |
serum sample | 7 |
aortic endothelial | 7 |
prrsv nc | 7 |
envelope protein | 7 |
epizootic outbreak | 7 |
porcine ifn | 7 |
roslin institute | 7 |
available online | 7 |
suis infection | 7 |
peak viremia | 7 |
course doses | 7 |
intramuscular injection | 7 |
respiratory impedance | 7 |
engineered pigs | 7 |
diabetes mellitus | 7 |
monoclonal antibodies | 7 |
virus porcine | 7 |
distance metric | 7 |
mediated cytotoxicity | 7 |
adapted virus | 7 |
nk cell | 7 |
use committee | 7 |
type prrsv | 7 |
small intestinal | 7 |
protective efficacy | 7 |
pigs often | 7 |
scavenger receptor | 7 |
pork industry | 7 |
cas system | 7 |
identifi cation | 7 |
one report | 7 |
esvac project | 7 |
disease control | 7 |
bovsdp group | 7 |
delivery systems | 7 |
production system | 7 |
pancreatic islets | 7 |
qiime script | 7 |
disease process | 7 |
blood monocytes | 7 |
facs buffer | 7 |
rjxwn contact | 7 |
also detected | 7 |
different treatment | 7 |
pigs purchased | 7 |
respiratory diseases | 7 |
animals may | 7 |
treated animals | 7 |
one outbreak | 7 |
way anova | 7 |
first clinical | 7 |
lysis buffer | 7 |
gene therapy | 7 |
upper airway | 7 |
iv strain | 7 |
virus clearance | 7 |
breeding sows | 6 |
maternally derived | 6 |
different routes | 6 |
clinical studies | 6 |
pigs throughout | 6 |
community composition | 6 |
one animal | 6 |
cytopathic effect | 6 |
western blot | 6 |
oral examination | 6 |
decreased susceptibility | 6 |
blood count | 6 |
presenting cells | 6 |
intestinal wall | 6 |
research facility | 6 |
using different | 6 |
bovine plasma | 6 |
nasal cavities | 6 |
phylogenetic diversity | 6 |
opportunistic infections | 6 |
feed conversion | 6 |
chlamydia psittaci | 6 |
repeated measures | 6 |
pig inclusion | 6 |
body weights | 6 |
life cycle | 6 |
specific immune | 6 |
color score | 6 |
well plates | 6 |
beta diversity | 6 |
intestinal specimens | 6 |
two days | 6 |
human primates | 6 |
citrobacter rodentium | 6 |
complete genome | 6 |
swine breeding | 6 |
also demonstrated | 6 |
alkaline phosphatase | 6 |
studies revealed | 6 |
prrsv infected | 6 |
rna extraction | 6 |
goat anti | 6 |
interalveolar septa | 6 |
choriomeningitis virus | 6 |
iv infection | 6 |
following infection | 6 |
mediated immune | 6 |
pigs tested | 6 |
dko pams | 6 |
cell populations | 6 |
local immune | 6 |
columns represent | 6 |
sense rna | 6 |
systematic review | 6 |
py script | 6 |
also found | 6 |
commercial swine | 6 |
graphs show | 6 |
weighted unifrac | 6 |
term survival | 6 |
gross pathology | 6 |
first column | 6 |
research institute | 6 |
using crispr | 6 |
veterinary institute | 6 |
chinese prrsv | 6 |
pig value | 6 |
conventional pig | 6 |
pcr amplification | 6 |
influenza vaccine | 6 |
acute porcine | 6 |
ottingen minipigs | 6 |
time rt | 6 |
hair follicles | 6 |
animal production | 6 |
respiratory pathogens | 6 |
differentially expressed | 6 |
immunity cytokines | 6 |
genomic copies | 6 |
transgenic animals | 6 |
cheek teeth | 6 |
boost pigs | 6 |
husbandry practices | 6 |
also observed | 6 |
prrsv vr | 6 |
among groups | 6 |
gas exchange | 6 |
enhance antigen | 6 |
human infectious | 6 |
clinically normal | 6 |
treatment plants | 6 |
observed within | 6 |
strain pc | 6 |
bacterial diversity | 6 |
genetic engineering | 6 |
statistical significance | 6 |
syndrome coronavirus | 6 |
rabies virus | 6 |
significant effect | 6 |
meat color | 6 |
statistical analyses | 6 |
tumor necrosis | 6 |
cytokine responses | 6 |
cd expression | 6 |
prolonged survival | 6 |
recent advances | 6 |
citrobacter spp | 6 |
remaining columns | 6 |
reference sequences | 6 |
respiratory problems | 6 |
may cause | 6 |
macrophage numbers | 6 |
prrsv load | 6 |
least one | 6 |
previously published | 6 |
health problems | 6 |
derived antibodies | 6 |
actinobacillus suis | 6 |
papn may | 6 |
eurasian avian | 6 |
ulcerative pododermatitis | 6 |
kidney cell | 6 |
iowa state | 6 |
differences among | 6 |
confinement buildings | 6 |
may occur | 6 |
field isolates | 6 |
buying live | 6 |
pathogen free | 6 |
human influenza | 6 |
trader characteristics | 6 |
inflammatory cytokine | 6 |
animal rule | 6 |
us porcine | 6 |
observation period | 6 |
pg ml | 6 |
en el | 6 |
pigs lacking | 6 |
pedv strain | 6 |
porcine kidney | 6 |
severe respiratory | 6 |
fecal shedding | 6 |
pairwise distances | 6 |
pcr product | 6 |
copy numbers | 6 |
molecular characterization | 6 |
litter size | 6 |
ha gene | 6 |
food safety | 6 |
gi fl | 6 |
throughput rtpcr | 6 |
nucleic acids | 6 |
porcine adrenal | 6 |
studies using | 6 |
may lead | 6 |
complement inhibitors | 6 |
autogenous vaccines | 6 |
horizontal transmission | 6 |
type ii | 6 |
virus titers | 6 |
dk variant | 6 |
drinking water | 6 |
bacterial pathogens | 6 |
virus vaccines | 6 |
nkp nk | 6 |
animals infected | 6 |
isolate vr | 6 |
coinfected pigs | 6 |
pig models | 6 |
pigs carrying | 6 |
pig breeding | 6 |
pigs naturally | 6 |
dna sequencing | 6 |
swine confinement | 6 |
antibody test | 6 |
highly virulent | 6 |
niv outbreaks | 6 |
graphpad prism | 6 |
del virus | 6 |
coronavirus disease | 6 |
strain rjxwn | 6 |
histological examination | 6 |
necrotizing bronchopneumonia | 6 |
pcv infection | 6 |
post infection | 6 |
complement regulatory | 6 |
wt pams | 6 |
modified animals | 6 |
ct value | 6 |
taxonomic profile | 6 |
swab samples | 6 |
control pig | 6 |
young pigs | 6 |
significant elevations | 6 |
increased significantly | 6 |
pcr testing | 6 |
cause severe | 6 |
chirodiscoides caviae | 6 |
several studies | 6 |
via ingestion | 6 |
different time | 6 |
infectious virus | 6 |
suckling pigs | 6 |
korean bastvs | 6 |
affected tissues | 6 |
enfermaron tras | 6 |
large numbers | 6 |
watery diarrhea | 6 |
human primate | 6 |
mean count | 6 |
macroscopic lung | 6 |
severe diarrhea | 6 |
respiratory system | 6 |
wide range | 6 |
ii cell | 6 |
lung function | 6 |
positive control | 6 |
high degree | 6 |
mesenteric lymph | 6 |
upper airways | 6 |
food producing | 6 |
local tissues | 6 |
health monitoring | 6 |
vaccine candidates | 6 |
pleuropneumoniae serovar | 6 |
mediated gene | 6 |
breeding farms | 6 |
proteomic analysis | 6 |
polyanhydride nps | 6 |
cavian leukemia | 6 |
edited animals | 6 |
human patients | 6 |
fl uid | 6 |
column provides | 6 |
like receptor | 6 |
wild boar | 6 |
considered statistically | 5 |
young animals | 5 |
editing technology | 5 |
vaccine efficacy | 5 |
two recent | 5 |
na gene | 5 |
subunit vaccine | 5 |
clinical xenotransplantation | 5 |
producing animals | 5 |
vlps expressing | 5 |
infraorbital nerve | 5 |
via direct | 5 |
influenza infection | 5 |
tested positive | 5 |
microscopic examination | 5 |
open access | 5 |
article distributed | 5 |
authorized species | 5 |
free guinea | 5 |
lesions consistent | 5 |
detection system | 5 |
mass spectrometry | 5 |
pcr positive | 5 |
high titers | 5 |
production traits | 5 |
gross lung | 5 |
reproductive disorders | 5 |
induced higher | 5 |
livestock species | 5 |
genomic dna | 5 |
distilled water | 5 |
determine whether | 5 |
body condition | 5 |
pork producers | 5 |
viral pathogens | 5 |
type virus | 5 |
major histocompatibility | 5 |
commonly associated | 5 |
organ failure | 5 |
pigs produced | 5 |
macrolides used | 5 |
secondary antibody | 5 |
target sites | 5 |
primate xenotransplantation | 5 |
porcine high | 5 |
modified live | 5 |
transmembrane envelope | 5 |
acute inflammatory | 5 |
lung lesion | 5 |
kurloff cell | 5 |
balf cells | 5 |
pcv subtype | 5 |
live porcine | 5 |
slaughtered animals | 5 |
nasal swab | 5 |
results indicate | 5 |
intestine tissues | 5 |
serum dilution | 5 |
per pen | 5 |
study showed | 5 |
higher prices | 5 |
eradication programs | 5 |
intestinal tract | 5 |
persistent infection | 5 |
us million | 5 |
abundant taxa | 5 |
target organ | 5 |
mean survival | 5 |
richness estimates | 5 |
health risks | 5 |
swine group | 5 |
data collected | 5 |
stem cell | 5 |
binding protein | 5 |
pcr products | 5 |
thymic atrophy | 5 |
campylobacter jejuni | 5 |
dendritic cell | 5 |
pathogenic prrsv | 5 |
surface staining | 5 |
approximately days | 5 |
boost vaccination | 5 |
rhesus macaques | 5 |
abdominal cavity | 5 |
shaded area | 5 |
may help | 5 |
gland tissue | 5 |
pigs used | 5 |
pcv replication | 5 |
protein expression | 5 |
remaining pigs | 5 |
vertical transmission | 5 |
caviae infestation | 5 |
cell activation | 5 |
traders reported | 5 |
infected piglets | 5 |
antibody testing | 5 |
negative throughout | 5 |
ocular discharge | 5 |
cd srcr | 5 |
du virus | 5 |
pig farming | 5 |
nlg site | 5 |
vaccine groups | 5 |
taxa identified | 5 |
different iv | 5 |
wide variety | 5 |
substantial increase | 5 |
virus induces | 5 |
like receptors | 5 |
mhc class | 5 |
sarcoptic mange | 5 |
cardiac xenotransplantation | 5 |
recombinant proteins | 5 |
pcr system | 5 |
total wbc | 5 |
infection may | 5 |
fluorescent antibody | 5 |
inoculated groups | 5 |
density lipoprotein | 5 |
growth rate | 5 |
severe lesions | 5 |
red blood | 5 |
veterinary pathologist | 5 |
become infected | 5 |
ad libitum | 5 |
human cytomegalovirus | 5 |
pandemic strain | 5 |
pedv igg | 5 |
pigs without | 5 |
ncbi genbank | 5 |
fetal death | 5 |
min followed | 5 |
porcine lymphotropic | 5 |
disease may | 5 |
intestinal lesions | 5 |
cell proliferation | 5 |
low morbidity | 5 |
significantly associated | 5 |
course dose | 5 |
without clinical | 5 |
tested negative | 5 |
histologic lesions | 5 |
controls compared | 5 |
sequencing depth | 5 |
pathologic changes | 5 |
pathological examination | 5 |
statistical software | 5 |
intestinal mucosa | 5 |
laboratory colonies | 5 |
mini kit | 5 |
virus strains | 5 |
holiday periods | 5 |
washed twice | 5 |
will increase | 5 |
close proximity | 5 |
cell transplantation | 5 |
ae se | 5 |
effective treatment | 5 |
antiviral drugs | 5 |
initial infection | 5 |
pigs will | 5 |
rectal swabs | 5 |
pcr assays | 5 |
pig workers | 5 |
cd gene | 5 |
japanese encephalitis | 5 |
possibly due | 5 |
human genes | 5 |
physical examination | 5 |
macrophage activation | 5 |
treg frequencies | 5 |
vt kg | 5 |
norwegian fattening | 5 |
class ii | 5 |
ascorbic acid | 5 |
pedv inoculation | 5 |
sentinel pigs | 5 |
feed intake | 5 |
manifestations clinical | 5 |
fattening pig | 5 |
respiratory dc | 5 |
porcine endothelial | 5 |
laboratory rodents | 5 |
large intestine | 5 |
analysed using | 5 |
ct values | 5 |
decision makers | 5 |
per year | 5 |
auckland island | 5 |
duchenne muscular | 5 |
inoculated group | 5 |
human vaccine | 5 |
higher amounts | 5 |
two species | 5 |
genome sequence | 5 |
vaccine induced | 5 |
disease severity | 5 |
may play | 5 |
gray shaded | 5 |
commons attribution | 5 |
farm environment | 5 |
effective vaccines | 5 |
vaccine adjuvants | 5 |
distinct clustering | 5 |
cd low | 5 |
viral antigen | 5 |
present studies | 5 |
gi tract | 5 |
pulmonary dysfunction | 5 |
production performance | 5 |
first study | 5 |
access article | 5 |
donor pigs | 5 |
numerous studies | 5 |
farms sampled | 5 |
two major | 5 |
experimental reproduction | 5 |
exfoliative dermatitis | 5 |
one herd | 5 |
significant economic | 5 |
higher prevalence | 5 |
pcr master | 5 |
nine pigs | 5 |
institutional animal | 5 |
well documented | 5 |
isofl urane | 5 |
pedv antigen | 5 |
serum virus | 5 |
viral strain | 5 |
creative commons | 5 |
prices paid | 5 |
clinical animal | 5 |
reduced appetite | 5 |
live pig | 5 |
growth factor | 5 |
leptospira interrogans | 5 |
reading frame | 5 |
often noted | 5 |
per kilogram | 5 |
air sampling | 5 |
respiratory syncytial | 5 |
caviae infection | 5 |
found dead | 5 |
four pigs | 5 |
dpi compared | 5 |
human infections | 5 |
corynebacterium spp | 5 |
cell death | 5 |
regulated proteins | 5 |
reduced growth | 5 |
fully resistant | 5 |
acute outbreaks | 5 |
bovine parainfluenza | 5 |
also possible | 5 |
liver weight | 5 |
environmental bacteria | 5 |
hyperacute rejection | 5 |
humoral xenograft | 5 |
case fatality | 5 |
galactosyltransferase knockout | 5 |
cavian parainfluenza | 5 |
two weeks | 5 |
operating region | 5 |
sample clustering | 5 |
remained healthy | 5 |
cftr gene | 5 |
phase i | 5 |
island pigs | 5 |
also tested | 5 |
pedv iga | 5 |
phase response | 5 |
even though | 5 |
approximately weeks | 5 |
antigenic diversity | 5 |
dmd gene | 5 |
pig farm | 5 |
tgev infection | 5 |
virus transmission | 5 |
acute infection | 5 |
significant increases | 5 |
clinically healthy | 5 |
currently available | 5 |
six pigs | 5 |
technical assistance | 5 |
norwegian veterinary | 5 |
infect dis | 5 |
genital infection | 5 |
zoonotic disease | 5 |
pork consumption | 5 |
current status | 5 |
dna virus | 5 |
intranasal inoculation | 5 |
porcine aortic | 5 |
viral disease | 5 |
recent studies | 5 |
microbial diversity | 5 |
environmental factors | 5 |
stressed pigs | 5 |
veterinary antimicrobial | 5 |
zoonotic transmission | 5 |
hepatocyte proliferation | 5 |
desirable traits | 5 |
swine herd | 5 |
ambient temperature | 5 |
lung surface | 5 |
specific igg | 5 |
daily gain | 5 |
vectored vaccine | 5 |
facultative anaerobic | 5 |
deprived pigs | 5 |
farms throughout | 5 |
microbial communities | 5 |
genome editors | 5 |
international committee | 5 |
per herd | 5 |
antigenic site | 5 |
experimental pigs | 4 |
high price | 4 |
four weeks | 4 |
southeast asia | 4 |
systemic immune | 4 |
lacking cd | 4 |
approximately min | 4 |
id sampled | 4 |
heterologous virus | 4 |
using pig | 4 |
entamoeba caviae | 4 |
graphpad software | 4 |
respective phases | 4 |
related species | 4 |
groups infected | 4 |
par voie | 4 |
pigs displaying | 4 |
commercial elisa | 4 |
target species | 4 |
viral antigens | 4 |
swine infected | 4 |
pathogen transmission | 4 |
pork customers | 4 |
farrowing unit | 4 |
coordinate axes | 4 |
source herd | 4 |
blocked using | 4 |
pathogenic strain | 4 |
cd high | 4 |
nucleotide sequence | 4 |
diversity analyses | 4 |
mucosal hyperplasia | 4 |
time intervals | 4 |
variation observed | 4 |
results show | 4 |
virus emerging | 4 |
financial support | 4 |
sanger sequencing | 4 |
cells derived | 4 |
breeding programs | 4 |
elisa positive | 4 |
week made | 4 |
fi ndings | 4 |
livestock production | 4 |
virus followed | 4 |
three control | 4 |
etiologic agent | 4 |
environmentally resistant | 4 |
intracellular staining | 4 |
microbiological safety | 4 |
positive piglets | 4 |
low total | 4 |
median number | 4 |
thank dr | 4 |
viral shedding | 4 |
remained negative | 4 |
serosal surfaces | 4 |
prrsv replication | 4 |
encephalitis virus | 4 |
small interfering | 4 |
peripheral immune | 4 |
double transgenic | 4 |
seroprevalence levels | 4 |
marketing authorization | 4 |
ns gene | 4 |
pcr reaction | 4 |
pig disease | 4 |
several weeks | 4 |
diarrheic pigs | 4 |
virulent porcine | 4 |
pigs associated | 4 |
bacteriologic isolation | 4 |
plasma cells | 4 |
exact test | 4 |
bronchoalveolar fluids | 4 |
human nasal | 4 |
primary cloning | 4 |
assessed using | 4 |
high proportion | 4 |
study identified | 4 |
high titer | 4 |
iga levels | 4 |
generally considered | 4 |
low viable | 4 |
infect guinea | 4 |
lymphocytic infiltrates | 4 |
derived dendritic | 4 |
mesenchymal stem | 4 |
ml day | 4 |
sampled pigs | 4 |
challenge experiments | 4 |
circulating csf | 4 |
mycoplasma spp | 4 |
bacterial infection | 4 |
kurloff cells | 4 |
triplicate wells | 4 |
intracellular cytokine | 4 |
type dm | 4 |
relatively common | 4 |
lesions may | 4 |
atrophic enteritis | 4 |
functional human | 4 |
serological evidence | 4 |
vivo replication | 4 |
following experimental | 4 |
mock group | 4 |
serum levels | 4 |
among others | 4 |
normal range | 4 |
viral vectors | 4 |
well plate | 4 |
host defence | 4 |
les porcs | 4 |
prrsv resistance | 4 |
pigs increased | 4 |
virus titres | 4 |
complement activation | 4 |
primary pig | 4 |
experimental design | 4 |
serum compared | 4 |
high prevalence | 4 |
software used | 4 |
early induction | 4 |
three pigs | 4 |
intranasal intratracheal | 4 |
food animals | 4 |
bacterial isolation | 4 |
term abortions | 4 |
wild rodents | 4 |
intestinal epithelial | 4 |
papillary adenoma | 4 |
animal studies | 4 |
lung viral | 4 |
younger pigs | 4 |
genetic modifications | 4 |
pcv coinfection | 4 |
mutation rate | 4 |
hemagglutination inhibition | 4 |
virulent strains | 4 |
year period | 4 |
healthy guinea | 4 |
van andel | 4 |
large quantities | 4 |
metabolic body | 4 |
clostridium spp | 4 |
antibiotic resistance | 4 |
porcine coronaviruses | 4 |
veterinary diagnostic | 4 |
total born | 4 |
causes severe | 4 |
much higher | 4 |
biosecurity measures | 4 |
blood clot | 4 |
best achieved | 4 |
niv vaccines | 4 |
stranded dna | 4 |
rough hair | 4 |
viral diseases | 4 |
porcine coronavirus | 4 |
type infection | 4 |
pig colony | 4 |
flow cytometer | 4 |
highly efficient | 4 |
immune function | 4 |
human tissues | 4 |
experimental groups | 4 |
cd foxp | 4 |
animal course | 4 |
least weeks | 4 |
within days | 4 |
biological functions | 4 |
test results | 4 |
animal colonies | 4 |
inoculated pig | 4 |
nested pcr | 4 |
wt control | 4 |
nasal passages | 4 |
major differences | 4 |
infected animal | 4 |
primary antibody | 4 |
cerdos infectados | 4 |
acute lesions | 4 |
highly sensitive | 4 |
food containers | 4 |
physicochemical properties | 4 |
normal guinea | 4 |
therapy prevention | 4 |
often associated | 4 |
subunit vaccines | 4 |
companion animals | 4 |
culture infectious | 4 |
farmer nasopharynx | 4 |
newmarket scientific | 4 |
sas institute | 4 |
thoracic fluid | 4 |
targeted pigs | 4 |
prevent transmission | 4 |
infected cells | 4 |
deps identified | 4 |
open reading | 4 |
por via | 4 |
biomass repartition | 4 |
inflammatory responses | 4 |
chicken eggs | 4 |
cytokine chemokine | 4 |
genetic resistance | 4 |
observed clinical | 4 |
median value | 4 |
elevated serum | 4 |
old dko | 4 |
section affected | 4 |
rich domain | 4 |
final injection | 4 |
injectable products | 4 |
sterile pbs | 4 |
many parts | 4 |
specific nucleases | 4 |
cycle threshold | 4 |
bacteroidia represented | 4 |
positive cocci | 4 |
detectable viral | 4 |
active ingredients | 4 |
severe economic | 4 |
negative organisms | 4 |
liposome nps | 4 |
histopathological lesions | 4 |
strain chn | 4 |
pig serum | 4 |
cap protein | 4 |
sequence identity | 4 |
agricultural environment | 4 |
pigs immunized | 4 |
pig genome | 4 |
respiratory infection | 4 |
alveolar exudates | 4 |
nasal mucosa | 4 |
cause disease | 4 |
native csf | 4 |
weanling pigs | 4 |
therapeutic intensity | 4 |
hygiene hypothesis | 4 |
cd int | 4 |
first time | 4 |
blastn search | 4 |
concurrent infection | 4 |
stained cells | 4 |
six wt | 4 |
previous research | 4 |
mucosal vaccine | 4 |
pedv shedding | 4 |
also available | 4 |
infection results | 4 |
spontaneous breathing | 4 |
study aimed | 4 |
human medicine | 4 |
significantly decreased | 4 |
igg antibody | 4 |
genome may | 4 |
also showed | 4 |
veterinary practitioner | 4 |
regulated deps | 4 |
farmers compared | 4 |
sow herd | 4 |
infect humans | 4 |
animals died | 4 |
jmp pro | 4 |
pcr results | 4 |
slaughtered pigs | 4 |
used extensively | 4 |
sample collection | 4 |
pigs via | 4 |
virus hemoaglutinante | 4 |
given day | 4 |
influenza research | 4 |
principal inoculated | 4 |
pharmaceutical immunosuppression | 4 |
axes capturing | 4 |
immune systems | 4 |
irregular returns | 4 |
primers used | 4 |
resistant pigs | 4 |
short course | 4 |
virus protection | 4 |
transgenic swine | 4 |
receptor binding | 4 |
induced immunosuppression | 4 |
organ rejection | 4 |
one cluster | 4 |
exhibit decreased | 4 |
sci doi | 4 |
prrsv elisa | 4 |
show means | 4 |
first reported | 4 |
million pigs | 4 |
many cases | 4 |
liver injury | 4 |
high level | 4 |
table common | 4 |
care must | 4 |
confers resistance | 4 |
antibodies directed | 4 |
intestinal segments | 4 |
nutritional support | 4 |
respiporc flu | 4 |
surface markers | 4 |
blood collection | 4 |
veterinary vaccines | 4 |
study also | 4 |
clearance functions | 4 |
pcr assay | 4 |
weeks later | 4 |
ugx kg | 4 |
phylogenetic tree | 4 |
reproductive failures | 4 |
chronic infection | 4 |
listeria monocytogenes | 4 |
authorization holders | 4 |
salivary gland | 4 |
commercial spray | 4 |
north carolina | 4 |
swine production | 4 |
pigs vaccinated | 4 |
oral application | 4 |
disease models | 4 |
human organs | 4 |
contact groups | 4 |
pigs caused | 4 |
genetic changes | 4 |
negative animals | 4 |
disease processes | 4 |
genetically different | 4 |
animal plasma | 4 |
food intake | 4 |
testing positive | 4 |
seroneutralizing antibodies | 4 |
whole cell | 4 |
species including | 4 |
test kit | 4 |
genetic disease | 4 |
genetic selection | 4 |
resistant animals | 4 |
transgenic porcine | 4 |
competition elisa | 4 |
incidence proportion | 4 |
cell depletion | 4 |
health effects | 4 |
samples vs | 4 |
active ingredient | 4 |
cytokine expression | 4 |
antigen presenting | 4 |
pigs fed | 4 |
transplacental transmission | 4 |
zoonotic risk | 4 |
european swine | 4 |
niv outbreak | 4 |
virus spread | 4 |
pathological findings | 4 |
orally administered | 4 |
functional receptor | 4 |
bordetella spp | 4 |
viral respiratory | 4 |
neutralization assay | 4 |
serum ifna | 4 |
species barrier | 4 |
los cerdos | 4 |
infect pigs | 4 |
experimental models | 4 |
th cells | 4 |
function tests | 4 |
pdm subtypes | 4 |
dual infection | 4 |
naturally acquired | 4 |
prrsv nucleocapsid | 4 |
lesion scores | 4 |
systemic infection | 4 |
activation syndrome | 4 |
significantly reduced | 4 |
showing clinical | 4 |
subclinical infections | 4 |
corona virus | 4 |
metastrongylus lungworms | 4 |
virus date | 4 |
elisa kit | 4 |
virus stock | 4 |
trichinella spp | 4 |
cd protein | 4 |
lelystad virus | 4 |
heart disease | 4 |
human recipients | 4 |
particle size | 4 |
disease caused | 4 |
cdna synthesis | 4 |
host cell | 4 |
treatment status | 4 |
diagnostic testing | 4 |
virus neutralization | 4 |
macroscopic lesions | 4 |
derived fibroblasts | 4 |
lung sections | 4 |
lung section | 4 |
cell mass | 4 |
tritrichomonas caviae | 4 |
moderate lesions | 4 |
dual infections | 4 |
primarily gram | 4 |
daily weight | 4 |
veterinary antimicrobials | 4 |
culture media | 4 |
purchased live | 4 |
high seroprevalence | 4 |
contact swine | 4 |
adenomatous polyposis | 4 |
ha sequence | 4 |
cell counts | 4 |
highly productive | 4 |
vaccine banks | 4 |
multifactorial disease | 4 |
health information | 4 |
one case | 4 |
also provide | 4 |
phosphate buffered | 4 |
cecal contents | 4 |
deficient pigs | 4 |
tras un | 4 |
per total | 4 |
higher virus | 4 |
pregnant sows | 4 |
human ace | 4 |
product level | 4 |
primordial germ | 4 |
emerg infect | 4 |
fusion protein | 4 |
nasopharyngeal microbiota | 4 |
calves aged | 4 |
skin scrapings | 4 |
biomass distribution | 4 |
cytokine release | 4 |
i ifn | 4 |
prrsv vlps | 4 |
wild suids | 4 |
bronchiseptica pneumonia | 4 |
next generation | 4 |
times higher | 4 |
cytokine response | 4 |
upstream regulators | 4 |
sampling times | 4 |
world organization | 4 |
surgxfwlrq ri | 4 |
porcine model | 4 |
may affect | 4 |
cytopathic effects | 4 |
nucleotide sequences | 4 |
also induced | 4 |
pig studies | 4 |
primary cause | 4 |
isotype control | 4 |
trader operates | 4 |
two principal | 4 |
intestinal villi | 4 |
bovine serum | 4 |
defi nitive | 4 |
vaccine antigens | 4 |
editing reagents | 4 |
one day | 4 |
swiav infection | 4 |
acute humoral | 4 |
competing interests | 4 |
pigs generated | 4 |
circovirus associated | 4 |
therapeutic proteins | 4 |
infection include | 4 |
also used | 4 |
confidence level | 4 |
animals showed | 4 |
fi rst | 4 |
eastern region | 4 |
ppv infection | 4 |
provide new | 4 |
low price | 4 |
source locations | 4 |
dried porcine | 4 |
ribosomal dna | 4 |
indirect contact | 4 |
nucleotide identity | 4 |
relatively low | 4 |
intensive farming | 4 |
high mutation | 4 |
nasopharynx sampling | 4 |
early time | 4 |
ppv antibodies | 4 |
kg csf | 4 |
species level | 4 |
total volume | 4 |
fecal material | 4 |
joint swelling | 4 |
considered negative | 4 |
pairwise testing | 4 |
personal protective | 4 |
cause diarrhea | 4 |
virus isolate | 4 |
genes involved | 4 |
bama miniature | 4 |
per treatment | 4 |
severe clinical | 4 |
nucleocapsid protein | 4 |
mucosal immune | 4 |
common cause | 4 |
acute cases | 4 |
obligate intracellular | 4 |
ha protein | 4 |
total biomass | 4 |
plga nanoparticles | 4 |
national animal | 4 |
bacillus piliformis | 4 |
human cases | 4 |
two reports | 4 |
treatment includes | 4 |
airborne transmission | 4 |
asfv infection | 4 |
serologic testing | 4 |
prototype strain | 4 |
real time | 4 |
potential role | 4 |
widely used | 4 |
shock proteins | 4 |
virus neuraminidase | 4 |
infected groups | 4 |
animal science | 4 |
humoral immunity | 4 |
dried animal | 4 |
experimentally inoculated | 4 |
highest levels | 4 |
epizootic outbreaks | 4 |
data presented | 4 |
indicate significant | 4 |
microbial composition | 4 |
receptor cysteine | 4 |
reproductive tract | 4 |
mg per | 4 |
finish phase | 4 |
cytokines chemokines | 4 |
including guinea | 4 |
testing using | 4 |
type species | 4 |
gross necropsy | 4 |
coat quality | 4 |
male guinea | 4 |
longitudinal study | 4 |
nasal turbinates | 4 |
py qiime | 4 |
generation sequencing | 4 |
uninfected pigs | 4 |
tbln homogenates | 4 |
multiple comparisons | 4 |
organ transplantation | 4 |
nucleic acid | 4 |
ms ms | 4 |
papn protein | 4 |
free water | 4 |
definitive diagnosis | 4 |
virus particles | 4 |
containing fbs | 4 |
whole blood | 4 |
routine diagnostics | 4 |
circulating strains | 4 |
assessment studies | 4 |
cytokines locally | 4 |
yucatan miniature | 4 |
cloning efficiency | 4 |
pcr test | 4 |
well known | 4 |
low mortality | 4 |
mortem examination | 4 |
veal calves | 4 |
coordinate analysis | 4 |
samples tested | 4 |
tissues collected | 4 |
kdyh ehhq | 4 |
function testing | 4 |
individual pig | 4 |
hong kong | 4 |
dried plasma | 4 |
diagnostic laboratory | 4 |
middle ear | 4 |
confirm presence | 4 |
respiratory dysfunction | 4 |
farm animals | 4 |
lung lobes | 4 |
resistant bacteria | 4 |
nuclear factor | 4 |
potential therapies | 4 |
proteins involved | 4 |
group significance | 4 |
media containing | 4 |
taken together | 4 |
slaughter weight | 4 |
harvest season | 4 |
pcr detection | 4 |
increased expression | 4 |
nursery sites | 4 |
paired serum | 4 |
tract infections | 4 |
two main | 4 |
urinary calculi | 4 |
infectious dose | 4 |
commonly reported | 4 |
typical lesions | 4 |
measured associated | 4 |
permeabilization buffer | 4 |
swine health | 4 |
novel coronavirus | 4 |
studies showed | 4 |
brucella spp | 4 |
intestine tissue | 4 |
biological characteristics | 4 |
products authorized | 4 |
el virus | 4 |
stomach lumen | 4 |
oral mucosa | 4 |
pathogenesis guinea | 4 |
avirulent live | 4 |
swiav infections | 4 |
critical role | 4 |
respiratory virus | 4 |
parametric mann | 4 |
serum collected | 4 |
prepatent period | 4 |
like virus | 4 |
sevofl urane | 4 |
epidemic diarrhoea | 4 |
new coronavirus | 4 |
ja strain | 4 |
un tiempo | 4 |
oral intranasal | 4 |
spleen weight | 4 |
data analysis | 4 |
pigs postweaning | 4 |
zoonotic pathogen | 4 |
including humans | 4 |
bp deletion | 4 |
concurrent pcv | 4 |
highest sequence | 4 |
defi ciency | 4 |
different innate | 4 |
coronavirus infection | 4 |
different types | 4 |
four different | 4 |
delivery platforms | 4 |
herd owners | 4 |
van reeth | 4 |
clinical development | 4 |
gene knockout | 4 |
may contain | 4 |
protect pigs | 4 |
infection model | 4 |
chinese hp | 4 |
poor coat | 4 |
wild guinea | 4 |
rna viruses | 4 |
pig cd | 4 |
first described | 4 |
th century | 4 |
different type | 4 |
kramer adjustment | 4 |
exposed workers | 4 |
mild lesions | 4 |
insulin secretion | 4 |
clinical cases | 4 |
three different | 4 |
pigs received | 4 |
target site | 4 |
adrenal tissue | 4 |
vaccine controls | 4 |
many countries | 4 |
immunosuppressive protocols | 4 |
increased susceptibility | 4 |
dqg wkh | 4 |
measured using | 4 |
orf ab | 4 |
bioaerosols released | 3 |
nursery unit | 3 |
culture supernatants | 3 |
compartment morbidity | 3 |
disease seen | 3 |
virus isolated | 3 |
inflammatory infiltrate | 3 |
consensus sequences | 3 |
hair shafts | 3 |
wild boars | 3 |
aradicular hypsodont | 3 |
monocyte production | 3 |
supplementary materials | 3 |
sialic acid | 3 |
significant correlation | 3 |
colorectal cancer | 3 |
various diseases | 3 |
federal office | 3 |
parent strain | 3 |
seal group | 3 |
factor receptor | 3 |
greater igg | 3 |
also occurs | 3 |
coinfection status | 3 |
positive animal | 3 |
also performed | 3 |
macconkey agar | 3 |
different days | 3 |
relative humidity | 3 |
vitro study | 3 |
amplification cycles | 3 |
reverse zoonotic | 3 |
genomic characterization | 3 |
animal disease | 3 |
respiratory rates | 3 |
mediated apoptosis | 3 |
cell screening | 3 |
different subsets | 3 |
cortisol levels | 3 |
paid per | 3 |
global pandemic | 3 |
sustained antigen | 3 |
also occur | 3 |
structural basis | 3 |
microbial content | 3 |
genetic characterization | 3 |
nlg sites | 3 |
different porcine | 3 |
traders purchased | 3 |
also called | 3 |
vascular malformation | 3 |
high prices | 3 |
frequency range | 3 |
species repartition | 3 |
coronary heart | 3 |
among pig | 3 |
analysis software | 3 |
dv wkh | 3 |
inoculated animals | 3 |
frequencies hz | 3 |
concurrent prrsv | 3 |
studies conducted | 3 |
authors read | 3 |
chicken embryo | 3 |
dried bovine | 3 |
will often | 3 |
data indicate | 3 |
nodules may | 3 |
pdm virus | 3 |
xenogeneic hyperacute | 3 |
american countries | 3 |
intranuclear inclusion | 3 |
comprehensive review | 3 |
small animals | 3 |
adenoviral vector | 3 |
eighth report | 3 |
extensive proliferation | 3 |
tous les | 3 |
main aim | 3 |
clinically inspected | 3 |
middle east | 3 |
revealed acute | 3 |
outcome variables | 3 |
wkh nh | 3 |
imaging techniques | 3 |
positive controls | 3 |
mucous membranes | 3 |
mv kg | 3 |
gate prices | 3 |
occupational health | 3 |
cryptosporidium wrairi | 3 |
zinc resistance | 3 |
died within | 3 |
pdcov strain | 3 |
organisms may | 3 |
clinical illness | 3 |
veterinary pathologists | 3 |
remains unclear | 3 |
cell epitope | 3 |
salivary glands | 3 |
greiner bio | 3 |
became ill | 3 |
cells expressing | 3 |
principal infected | 3 |
typical clinical | 3 |
iga antibodies | 3 |
pigs seem | 3 |
fc conjugate | 3 |
host cells | 3 |
states swine | 3 |
adverse reactions | 3 |
gastric lumen | 3 |
linear model | 3 |
homologous virus | 3 |
swine workers | 3 |
minimizing stress | 3 |
cerebrospinal fluid | 3 |
vaccination regimens | 3 |
disease prevention | 3 |
induced pneumonia | 3 |
animals remained | 3 |
natural reservoir | 3 |
clinical practice | 3 |
respiratory viral | 3 |
caudal lobes | 3 |
identified four | 3 |
gastrointestinal tract | 3 |
farm level | 3 |
bacterial species | 3 |
may appear | 3 |
used following | 3 |
model organisms | 3 |
transmission occurs | 3 |
pregnancy toxemia | 3 |
sampling period | 3 |
life cycles | 3 |
still susceptible | 3 |
specific neutralizing | 3 |
sweat glands | 3 |
sample handling | 3 |
chao richness | 3 |
virus load | 3 |
reported treatment | 3 |
antigen release | 3 |
functional residual | 3 |
science associations | 3 |
first serum | 3 |
previously exposed | 3 |
per sample | 3 |
ingelvac prrs | 3 |
increased respiratory | 3 |
first discovered | 3 |
major economic | 3 |
gene sequences | 3 |
several porcine | 3 |
first sampling | 3 |
severe infections | 3 |
live attenuated | 3 |
nasal microbiota | 3 |
antigen retrieval | 3 |
standard weights | 3 |
another approach | 3 |
represents median | 3 |
small sections | 3 |
initially thought | 3 |
adult pigs | 3 |
editor reagents | 3 |
community structure | 3 |
emerging disease | 3 |
acute viral | 3 |
different prrsv | 3 |
first report | 3 |
information system | 3 |
affected piglets | 3 |
pig virus | 3 |
value chain | 3 |
cpg oligodeoxynucleotide | 3 |
ri sljv | 3 |
high fevers | 3 |
ml per | 3 |
results suggest | 3 |
giemsa stain | 3 |
glycolic acid | 3 |
wa isolate | 3 |
mean rectal | 3 |
caviid herpes | 3 |
pigs revealed | 3 |
previous findings | 3 |
normally distributed | 3 |
may die | 3 |
new insights | 3 |
transcription factor | 3 |
breeding herds | 3 |
genomic material | 3 |
human thrombomodulin | 3 |
least three | 3 |
circulating swine | 3 |
ml syringe | 3 |
acids present | 3 |
completely resistant | 3 |
long time | 3 |
contact animals | 3 |
antigenic drift | 3 |
bladder wall | 3 |
antibody titer | 3 |
treatment options | 3 |
human nk | 3 |
per milliliter | 3 |
groups coi | 3 |
future studies | 3 |
mean pcv | 3 |
antibiotic therapy | 3 |
old piglets | 3 |
hk cow | 3 |
donor animals | 3 |
chimpanzee adenovirus | 3 |
mouse anti | 3 |
wambizzi cooperative | 3 |
soluble form | 3 |
multiple gene | 3 |
expression profiles | 3 |
based nps | 3 |
yucatan minipigs | 3 |
intramuscularly inoculated | 3 |
pigs swine | 3 |
genetic modification | 3 |
samples showed | 3 |
less frequently | 3 |
may reveal | 3 |
production type | 3 |
higher level | 3 |
taxonomic groups | 3 |
major pig | 3 |
antigen delivery | 3 |
damage caused | 3 |
nasal secretions | 3 |
brachyspira hyodysenteriae | 3 |
contaminated food | 3 |
signs developed | 3 |
ill thrift | 3 |
pig feed | 3 |
respiratory infections | 3 |
business operation | 3 |
higher frequency | 3 |
computed tomography | 3 |
mediated immunity | 3 |
individual mouse | 3 |
swine origin | 3 |
pigs exhibit | 3 |
nps enhance | 3 |
associated colitis | 3 |
delayed clearance | 3 |
previous results | 3 |
fecal smears | 3 |
disease progression | 3 |
cells used | 3 |
cohort study | 3 |
severe morbidity | 3 |
pigs killed | 3 |
quantitative pcr | 3 |
product authorized | 3 |
test gases | 3 |
might give | 3 |
endogenous peroxidase | 3 |
transplant recipient | 3 |
chitosan nanoparticles | 3 |
immunosuppressive treatments | 3 |
adult guinea | 3 |
fecal sample | 3 |
bottom plates | 3 |
pcv viremia | 3 |
risk factor | 3 |
respiratory illness | 3 |
maximum survival | 3 |
erysipelothrix rhusiopathiae | 3 |
prevention strategies | 3 |
via contact | 3 |
protein source | 3 |
may include | 3 |
five control | 3 |
specific ifn | 3 |
mononuclear cell | 3 |
copy number | 3 |
per minute | 3 |
two control | 3 |
linked glycosylation | 3 |
data suggesting | 3 |
various immunosuppressive | 3 |
pathologist blinded | 3 |
viruses circulating | 3 |
significantly induced | 3 |
int mhc | 3 |
different variants | 3 |
cytokines il | 3 |
adult cattle | 3 |
infl ammation | 3 |
control programs | 3 |
recorded daily | 3 |
recent reports | 3 |
viable pigs | 3 |
significant impact | 3 |
stress factors | 3 |
important swine | 3 |
pig diet | 3 |
electronic supplementary | 3 |
us pork | 3 |
fungal infections | 3 |
diagnostic laboratories | 3 |
klossiella cobayae | 3 |
todos los | 3 |
severe atrophic | 3 |
solid organs | 3 |
pigs results | 3 |
low levels | 3 |
enteric infections | 3 |
nine resistant | 3 |
necrotizing enteritis | 3 |
may hinder | 3 |
captive bolt | 3 |
cell morphology | 3 |
mononuclear phagocyte | 3 |
labored breathing | 3 |
also contains | 3 |
averaged per | 3 |
another option | 3 |
surface affected | 3 |
species transmission | 3 |
perfringens type | 3 |
vaccine also | 3 |
pharmaceutical proteins | 3 |
acid deletion | 3 |
early infection | 3 |
galactosyltransferase gene | 3 |
large amount | 3 |
united kingdom | 3 |
sequences using | 3 |
one another | 3 |
without antibiotics | 3 |
article includes | 3 |
face mask | 3 |
emerging strains | 3 |
cell colonies | 3 |
bovine astrovirus | 3 |
human viral | 3 |
control environment | 3 |
negative correlation | 3 |
using qiime | 3 |
mean weight | 3 |
clinical outbreaks | 3 |
xenotransplantation xenotransplantation | 3 |
oral rehydration | 3 |
isolate nc | 3 |
porcine enteric | 3 |
day old | 3 |
hemolytic streptococcus | 3 |
potential animal | 3 |
feedback loop | 3 |
acute pedv | 3 |
genome sequencing | 3 |
farrowing crates | 3 |
physiological incompatibility | 3 |
px vector | 3 |
normal distribution | 3 |
bold type | 3 |
two veterinary | 3 |
kupffer cells | 3 |
preferred buying | 3 |
virus derived | 3 |
antibody detection | 3 |
analysis thereof | 3 |
pigs around | 3 |
usda aphis | 3 |
also important | 3 |
res doi | 3 |
viruses may | 3 |
risk ratio | 3 |
neuros strain | 3 |
rna shedding | 3 |
us swine | 3 |
two strains | 3 |
antigenic variants | 3 |
male farmers | 3 |
project license | 3 |
first pregnancy | 3 |
human lysozyme | 3 |
blood sampling | 3 |
control groups | 3 |
dental malocclusion | 3 |
adverse effects | 3 |
familial adenomatous | 3 |
severe interstitial | 3 |
giardia duodenalis | 3 |
multivariate analysis | 3 |
particle vaccine | 3 |
cell membrane | 3 |
group pigs | 3 |
trinidadian domestic | 3 |
gating strategy | 3 |
cattle brain | 3 |
human consumption | 3 |
prevalence rates | 3 |
response may | 3 |
ha region | 3 |
pathogen exposure | 3 |
developmental stages | 3 |
killer cell | 3 |
defence system | 3 |
pulmonary alveolar | 3 |
donor pig | 3 |
may develop | 3 |
permanova test | 3 |
rural affairs | 3 |
findings highlight | 3 |
breeding age | 3 |
edema disease | 3 |
encephalomyocarditis virus | 3 |
gnotobiotic pig | 3 |
another possible | 3 |
pairwise comparison | 3 |
well recognized | 3 |
st cells | 3 |
ingenuity pathway | 3 |
fluorescence microscope | 3 |
transmitted via | 3 |
swabs blood | 3 |
swine study | 3 |
virus belonging | 3 |
total liver | 3 |
oie world | 3 |
simian virus | 3 |
study sars | 3 |
vet res | 3 |
equine group | 3 |
veterinary microbiology | 3 |
pig development | 3 |
commonly isolated | 3 |
cryptosporidium organisms | 3 |
report describes | 3 |
animal demographics | 3 |
randomly selected | 3 |
intravenous inoculation | 3 |
may predispose | 3 |
papn functions | 3 |
forward primer | 3 |
immunized pigs | 3 |
nervous disorders | 3 |
respiratory viruses | 3 |
management practices | 3 |
different levels | 3 |
affected area | 3 |
superficial inguinal | 3 |
conjugated goat | 3 |
research council | 3 |
mixing vessel | 3 |
infection causes | 3 |
raccoon feces | 3 |
belgian swine | 3 |
diseased pigs | 3 |
method used | 3 |
residual capacity | 3 |
using trizol | 3 |
detect antibodies | 3 |
similar results | 3 |
ohio state | 3 |
vesicular stomatitis | 3 |